IFAPP Academy Faculty
<center>Ahmed Shelbaya, MD</center>

Ahmed Shelbaya, MD

Senior Director Global Health Outcomes Research, Pfizer
<center>Professor Alan Boyd (FPM)</center>

Professor Alan Boyd (FPM)

Past President of the Faculty of Pharmaceutical Medicine, CEO & Founder of Boyds and Consultant Pharmaceutical Physician
<center>Amber Whybro</center>

Amber Whybro

Senior Director Clinical Operations UK & Ireland at Quintiles
<center>Anna Van Troostenburg De Bruyn</center>

Anna Van Troostenburg De Bruyn

EU QPPV and VP Pharmacovigilance & Epidemiology at Gilead Sciences
<center>Beate Schmidt, MSc, MDRA, RAC</center>

Beate Schmidt, MSc, MDRA, RAC

Freelance regulatory consultant to the pharma and biotech industry
<center>Dr. Bill Lam</center>

Dr. Bill Lam

Director, Clinical Site Management - Australia/NZ/South Africa at Pfizer
<center>Brenda Raphael</center>

Brenda Raphael

Senior Vice President, General Manager Bayer Consumer
<center>Brian Gennery, MBE, FRCP, FFPM</center>

Brian Gennery, MBE, FRCP, FFPM

Visiting Professor, Institute of Pharmaceutical Sciences at King’s College London
<center>Carl Naraynassamy</center>

Carl Naraynassamy

Visiting Senior Lecturer, King’s College London
<center>Dr. Christopher-Paul Milne</center>

Dr. Christopher-Paul Milne

Retired Director of Research at Tufts CSDD
<center>Daniel García Molinero</center>

Daniel García Molinero

Senior Regulatory Manager at Drug Development and Regulation (DDR)
<center>David Morgan, MA, MSc, CStat, CMath</center>

David Morgan, MA, MSc, CStat, CMath

Statistical Consultant
<center>David Raunig, Ph.D.</center>

David Raunig, Ph.D.

Sr. Principal Imaging Statistician at ERT
<center>Domenico Criscuolo, MD, PhD</center>

Domenico Criscuolo, MD, PhD

Past President of the Italian Association of Pharmaceutical Medicine) and IFAPP, Italian SMD Team Lead
<center>Dominique Dubois, MD, FBCPM, FFPM</center>

Dominique Dubois, MD, FBCPM, FFPM

Editor-in-Chief of Frontiers in Pharmaceutical Medicine & Outcomes Research
<center>Edward Power PhD, MBA</center>

Edward Power PhD, MBA

Vice President, North America Medical Affairs, Hospital Business at Pfizer
<center>Greg Koski, PhD, MD</center>

Greg Koski, PhD, MD

Co-Founder at Alliance for Clinical Research Excellence and Safety, ACRES
<center>Helene Schluep, MD</center>

Helene Schluep, MD

Global Medical Affairs, Pfizer
<center>Jacqui Piner, PhD</center>

Jacqui Piner, PhD

Scientific Director, GSK, GSK Fellow
<center>Javier Coindreau</center>

Javier Coindreau

Vice-President Global Medical Affairs at Gilead Sciences
<center>Jeff Duke, M.Sc, C.Chem, C.Sci, FRSC</center>

Jeff Duke, M.Sc, C.Chem, C.Sci, FRSC

Consultant, Grove Lodge Consulting
<center>John Alter</center>

John Alter

VP, Patient and Health Impact Lead, Hospital Business Unit at Pfizer
<center>Dr. Kamlesh Thakker PhD, MBA</center>

Dr. Kamlesh Thakker PhD, MBA

Principal at Notting Hill Consulting LLC
<center>Larry Kennedy, PhD</center>

Larry Kennedy, PhD

CEO, Quality Management Institute; Co-Founder and V.P Quality Management Systems, ACRES ReServ
<center>Lisa Egbuonu-Davis MD, MPH, MBA</center>

Lisa Egbuonu-Davis MD, MPH, MBA

Vice President, Global Patient Centered Outcomes and Solutions at Sanofi
<center>Mike Collins Ph.D., CStat</center>

Mike Collins Ph.D., CStat

Owner at Mike Collins Consulting LLC
<center>Nikolas Karkanias, Ph.D.</center>

Nikolas Karkanias, Ph.D.

Senior Director, Field Based Medical Lead for Oncology Biosimilars in the U.S., Pfizer
<center>Dr. Omar Antonio Alvarez-Pousa</center>

Dr. Omar Antonio Alvarez-Pousa

Information Technology Services Director at Zoetis Inc. (former Pfizer Animal Health) ; New York University Professor
<center>Peter Šajben, MD</center>

Peter Šajben, MD

Vice President, Regional Head Medical Affairs, Africa & Middle East Region, Pfizer Essential Health
<center>Pol Vandenbroucke, MD, MSc, MBA, FFPM</center>

Pol Vandenbroucke, MD, MSc, MBA, FFPM

Chief Medical Officer Pfizer Hospital Business Unit
<center>Pravin Chopra, MD</center>

Pravin Chopra, MD

Independent Global Life Sciences Medical Executive
<center>Dr. Rory O’Connor</center>

Dr. Rory O’Connor

SVP, Chief Medical Officer, Internal Medicine, Pfizer Innovative Health

<center>Sandor Kerpel-Fronius, M.D., D.Sc.</center>

Sandor Kerpel-Fronius, M.D., D.Sc.

Professor of Clinical Pharmacology. Department of Pharmacology and Pharmacotherapy. Semmelweis Medical University. Budapest, Hungary
<center>Seema Haider, PhD</center>

Seema Haider, PhD

Senior Director, Team Lead Global Established Products & Biosimilars, Outcomes & Evidence at Pfizer
<center>Shayesteh Fürst-Ladani, MSc, MBA</center>

Shayesteh Fürst-Ladani, MSc, MBA

CEO of SFL Group of Companies
<center>Shoibal Mukherjee, MD, DM</center>

Shoibal Mukherjee, MD, DM

VP & Head, Asia Medical Sciences Group at Quintiles
<center>Soneil Guptha, MD, FACC, FESC, AFPM</center>

Soneil Guptha, MD, FACC, FESC, AFPM

Independent pharmaceutical physician and consultant in pharmaceutical medicine (Drug & Device Development and Drug Regulation)
<center>Susy Davis</center>

Susy Davis

Director, SLD Solutions Ltd
<center>Syed Kazmi, PhD, MBA</center>

Syed Kazmi, PhD, MBA

Vice President, Global Head Business Development & Licensing, Novartis Oncology
<center>Tamás Sütő MD, PhD, MICR (Sanofi)</center>

Tamás Sütő MD, PhD, MICR (Sanofi)

Global Head of Medical Capability Development, Sanofi
<center>Tony Fox, MSc, MBBS, MD(Lond) </center>

Tony Fox, MSc, MBBS, MD(Lond)

Manging Director / President at EBD London Ltd / EBD Consulting Inc, Nevada
<center>Xavier Luria, MD</center>

Xavier Luria, MD

Independent consultant on Drug Development and Drug Regulation, located in Barcelona and London
<center>Zaide Frias, MBA</center>

Zaide Frias, MBA

Head of Regulatory Affairs at EMEA